Do you think your technology or research could be complementary to ours?
Arquer Diagnostics has a programme of active collaborations with companies, research groups and clinicians
Arquer is interested in opportunities for in-licensing cancer biomarkers or technologies where there is a fit with our current platform and products.
Arquer Diagnostics’ assay platform is readily adaptable for the detection of other cancer biomarkers, so provides a rapid route to market based on proven technology.
If your business, university department, other scientific or medical organisation has cancer biomarkers or technologies that might be suitable licensing candidates, please get in touch.
Do you have a clinical trial or a sampling device that may be compatible with Arquer’s technology? If you are interested in collaborating with Arquer in the development of a cancer diagnostic, please get in touch.